User menu

Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia.

Bibliographic reference Millot, Frédéric ; Guilhot, Joelle ; Nelken, Brigitte ; Leblanc, Thierry ; Leverger, Guy ; et. al. Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia.. In: Pediatric blood & cancer, Vol. 47, no. 5, p. 555-9 (2006)
Permanent URL http://hdl.handle.net/2078.1/27169
  1. Guilhot, N Engl J Med, 337, 223 (1997)
  2. Kantarjian, J Clin Oncol, 17, 284 (1999)
  3. Thaler, Leukemia Res, 21, 75 (1997)
  4. Arthur C.K., Ma D.D.F., Combined Interferon Alfa-2a and Cytosine Arabinoside as First-Line Treatment for Chronic Myeloid Leukemia, 10.1159/000204580
  5. Millot, J Ped Hematol Oncol, 24, 18 (2002)
  6. National Cancer Institute Guidelines for Reporting of Adverse Drug Reactions. Bethesda, MD, Division of Cancer Treatment, National Cancer Institute, 1988.
  7. Dow, Cancer, 68, 1678 (1991)
  8. Talpaz Moshe, Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia : Philadelphia Chromosome-Positive Patients, 10.7326/0003-4819-114-7-532
  9. The Italian Cooperative Group on chronic myeloid leukemia, Blood, 92, 1541 (1998)
  10. Allan, Lancet, 345, 1392 (1995)
  11. Kantarjian, J Clin Oncol, 10, 772 (1992)
  12. Baccarani, Blood, 9, 1527 (2002)
  13. O'Brien, N Engl J Med, 348, 994 (2003)
  14. Millot, Blood, 102, 183 (2003)
  15. Champagne, Blood, 104, 2655 (2004)
  16. Cwynarski, Blood, 102, 1224 (2003)
  17. Millot, Bone Marrow Transplant, 32, 933 (2003)